Showing results (61-70 of 111) with videos related to
Sort By:
Pageof 12
BMC Cancer|May 21, 2026
EGFR-TKI monotherapy versus combination therapy as first-line treatment for EGFR-mutant NSCLC with brain metastases: a real-world comparison analysisFei Qi, Yuzhu Chen, Yi Han, et al.Cellular Signalling|April 17, 2025
The transcription factor BMAL1 inhibits endothelial cell apoptosis by targeting STAT6 to repress its expressionQi Yang, Ya'nan Liang, Rui Wang, et al.Therapeutic Advances in Medical Oncology|July 17, 2025
The IASLC uncertain resection, general overview, current evidence, and future prospects: a systematic review and meta-analysisMingming Hu, Xiaomi Li, Maike Zheng, et al.BMC Medicine|September 10, 2024
Integration of clinical and blood parameters in risk prognostication for patients receiving immunochemotherapy for extensive stage small cell lung cancer: real-world data from two centersXiaomi Li, Li Tong, Shan Wang, et al.Brain, Behavior, and Immunity|May 19, 2025
SORLA Orchestrates microglial dynamics for enhanced neuroprotection and recovery following ischemic strokeSehui Ma, Tongmei Zhang, Junkai Lv, et al.Science Advances|March 28, 2025
WWC1 mutation drives dopamine dysregulation and synaptic imbalance in Tourette's syndromeJunkai Lv, Shiqi Liang, Pengwei Qin, et al.Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|August 27, 2016
[Serum CYFRA21-1 is Correlated with the Efficacy of Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor in Non-small Cell Lung Cancer Patients Harboring EGFR Mutations]Qunhui Wang, Hua Zheng, Fanbin Hu, et al.Scientific Reports|January 28, 2022
Sodium-calcium exchanger isoform-3 targeted Withania somnifera (L.) Dunal therapeutic intervention ameliorates cognition in the 5xFAD mouse model of Alzheimer's diseaseHenok Kessete Afewerky, Hao Li, Tongmei Zhang, et al.Journal of Translational Medicine|August 19, 2025
Multimodal prediction of tyrosine kinase inhibitors therapy outcomes in advanced EGFR-mutated NSCLC patientsXiaodong Chai, Hongxia Li, Moxuan Yang, et al.Respiratory Research|March 21, 2026
The Wnt receptor Frizzled3 (FZD3) drives aggressive phenotypes in small cell lung cancerMingjun Lu, Xiaoyue Zhu, Chenyang Wang, et al.Pageof 12